PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Expert outlines challenges of visual accessibility for people with low vision

Prentice lecture in optometry and vision science discusses new approaches to improving 'real-world' architectural and reading accessibility

2014-06-24
(Press-News.org) June 24, 2014 – New approaches and tools are needed to improve visual accessibility for people with low vision in the "real world," according to a special article in the July issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. Vision science, in collaboration with other professions, has a key role in developing technologies and design approaches to promote visual accessibility for the millions of people living with low vision, according to the review by Gordon E. Legge, PhD, of University of Minnesota. In recognition of his pioneering work on low-vision research and visual accessibility, Dr Legge was named the 2013 Charles F. Prentice Award Lecture Medalist.

Visual accessibility for people with low vision—challenges and new approaches Low vision is defined as chronically impaired vision that is not correctable by glasses or contact lenses and adversely affects everyday functioning. It is estimated that there are between 3.5 million and 5 million Americans with low vision, and this number is expected to increase as the population ages.

In his Prentice Lecture, Dr Legge—himself a person with low vision—proposes to "embed low-vision research more explicitly in the real world" in order to reduce barriers to visual accessibility, He shares examples of his research in two key areas: architectural accessibility and reading accessibility.

Architectural design can enhance visual accessibility for people with low vision. Dr Legge gives illustrated examples of how low vision can make it difficult to navigate architectural spaces; the obstacles and hazards may even change with the light at different times of day.

His research includes the development of software tools to promote the design of visually accessible spaces. These tools help in representing the impact of reduced visual acuity and contrast sensitivity, as well as predicting whether architectural features can be seen by people with low vision. Dr Legge writes, "We need practical models of low vision capable of predicting real-world object visibility."

Dr Legge's work also includes efforts to increase reading accessibility for people with low vision. Advances such as electronic readers provide powerful new tools to improve reading accessibility, but there's still a lack of knowledge of how best to use the features they provide. Research is needed to understand the interacting effects of variables such as display geometry, visual acuity, viewing distance, print size, and font.

Dr Legge urges low-vision researchers to work with other disciplines—including software and hardware developers and design professionals—toward solving the problems of visual accessibility. He writes, "Where we succeed, we will contribute to vision science by showing how vision functions in the real world, and we will find better ways to reduce barriers facing people with visual impairment." For his outstanding history of insights and research in the field of low vision, Dr Legge was named winner of the American Academy of Optometry's Charles F. Prentice Medal for 2013. Established in 1958, the Charles F. Prentice Medal is awarded annually to an outstanding scientist who has contributed significantly to the advancement of knowledge in the visual sciences.

"Visual accessibility makes an environment, device, or display useable by those with low vision, comments Anthony Adams, OD, PhD, Editor-in-Chief of Optometry and Vision Science. "Our Prentice medalist is a world research leader in low vision and he gives us clear insight into the ways vision science plays an important role in enhancing visual accessibility for people with low vision."

Click here to read "Prentice Lecture 2013: Visual Accessibility: A Challenge for Low-Vision Research."

Click here to watch a video of the 2013 Charles Prentice Medal Lecture given by Dr. Legge.

INFORMATION: About Optometry and Vision Science Optometry and Vision Science, official journal of the American Academy of Optometry, is the most authoritative source for current developments in optometry, physiological optics, and vision science. This frequently cited monthly scientific journal has served primary eye care practitioners for more than 75 years, promoting vital interdisciplinary exchange among optometrists and vision scientists worldwide.

About the American Academy of Optometry Founded in 1922, the American Academy of Optometry is committed to promoting the art and science of vision care through lifelong learning. All members of the Academy are dedicated to the highest standards of optometric practice through clinical care, education or research.

About Wolters Kluwer Health Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health's market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Follow our official Twitter handle: @WKHealth.


ELSE PRESS RELEASES FROM THIS DATE:

Experts cite 'misconceptions' on brain metastases

2014-06-24
June 24, 2014 – "Key historical misconceptions" are hindering progress in research and treatment for patients with cancer metastases to the brain, suggests a special article in the July issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. Dr. Douglas Kondziolka of NYU Langone Medical Center and coauthors identify some issues that may be standing in the way of optimal clinical management for patients with cancer that has spread to the brain from other ...

New transdermal SARM drug for muscle-wasting offers hope for older cancer patients

2014-06-24
CHICAGO, IL—Muscle wasting that occurs as a result of cancer negatively impacts the well-being and recovery prospects of millions of patients, particularly the rapidly-growing elderly populations in Western societies. Drugs called selective androgen receptor modulators (SARMs) offer hope for these patients, and a new SARM for transdermal administration is promising excellent efficacy without harming liver function and HDL levels. Results and conclusions were presented Tuesday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO ...

Gender differences could mean more risk for cardiovascular death

2014-06-24
Queen's University assistant professor Pendar Farahani (Department of Medicine and Department of Public Health Sciences) is advocating the use of gender-based treatment for mitigating the cardiovascular risk factors related to diabetes. Research has shown women with Type 2 diabetes and high cholesterol are less likely than their male peers to reach treatment goals to lower their bad cholesterol, or low-density lipoprotein (LDL) cholesterol. "The findings suggest the need for gender-based evaluation and treatment of cardiovascular risk factors in these patients," says ...

Study finds high CD4 cell counts associated with reduced risk of ischemic stroke for those with HIV

2014-06-24
OAKLAND, Calif., June 24, 2014 — A 15-year study found that HIV-positive individuals had a 40 percent increased risk of ischemic stroke, however stroke rates were nearly the same for HIV-positive individuals with high CD4 cell counts as for HIV-negative subjects. The study, published recently in AIDS, the official journal of the International AIDS Society, covered the years 1996 through 2011 and included nearly 25,000 HIV-positive individuals. Ischemic stroke is caused by plaque build-up in blood vessels, which can lead to constriction or actual obstruction of blood ...

Bizarre parasite from the Jurassic

Bizarre parasite from the Jurassic
2014-06-24
Around 165 million years ago, a spectacular parasite was at home in the freshwater lakes of present-day Inner Mongolia (China): A fly larva with a thorax formed entirely like a sucking plate. With it, the animal could adhere to salamanders and suck their blood with its mouthparts formed like a sting. To date no insect is known that is equipped with a similar specialised design. The international scientific team is now presenting its findings in the journal "eLIFE". The parasite, an elongate fly larva around two centimeters long, had undergone extreme changes over the ...

Aging accelerates genomic changes, signaling challenges for personalized medicine

Aging accelerates genomic changes, signaling challenges for personalized medicine
2014-06-24
Exploiting individual genomes for personalized medicine may be more complicated than medical scientists have suspected, researchers at the Virginia Bioinformatics Institute of Virginia Tech have discovered. In a paper published in June in the journal Aging, scientists from the institute's Medical Informatics and Systems Division found that spontaneous mutations occur in our bodies constantly, but the rate of change differed dramatically among various people. The study has implications for personalized medicine, which will make use of genomic information to predict future ...

Young women with PCOS are 5 times more likely to develop type 2 diabetes

2014-06-24
A leading expert on reproductive health says young women with Polycystic Ovary Syndrome (PCOS) have a startlingly higher risk of developing type 2 diabetes, even if young and not overweight. The research led by Professor Helena Teede and Dr Anju Joham, from the School of Public Health and Preventive Medicine at Monash University analysed a large-scale epidemiological study, called the Australian Longitudinal Study of Women's Health, which revealed the findings. Over 6000 women aged between 25-28 years were monitored for nine years, including 500 with diagnosed PCOS. ...

New possibilities for leukemia therapy with a novel mode of leukemia cell recognition

2014-06-24
Singapore, 24 June 2014—Scientists at A*STAR's Singapore Immunology Network (SIgN) have discovered a new class of lipids in the leukaemia cells that are detected by a unique group of immune cells. By recognising the lipids, the immune cells stimulate an immune response to destroy the leukaemia cells and suppress their growth. The newly identified mode of cancer cell recognition by the immune system opens up new possibilities for leukaemia immunotherapy . Leukaemia is characterized by the accumulation of cancer cells originating from blood cells, in the blood or bone marrow. ...

NTU study shows puzzle games can improve mental flexibility

NTU study shows puzzle games can improve mental flexibility
2014-06-24
Want to improve your mental finesse? Playing a puzzle game like Cut the Rope could just be the thing you need. A recent study by Nanyang Technological University (NTU) scientists showed that adults who played the physics-based puzzle video game Cut the Rope regularly, for as little as an hour a day, had improved executive functions. The executive functions in your brain are important for making decisions in everyday life when you have to deal with sudden changes in your environment – better known as thinking on your feet. An example would be when the traffic light ...

Cancer: The roots of evil go deep in time

2014-06-24
Every year around 450,000 people in Germany are diagnosed with cancer. Each one of them dreams of a victory in the battle against it. But can cancer ever be completely defeated? Researchers at Kiel University (CAU) have now reached a sobering conclusion: "cancer is as old as multi-cellular life on earth and will probably never be completely eradicated", says Professor Thomas Bosch in his latest research results. The study by an international team led by Bosch was published today (Monday, June 24) in the prestigious scientific journal Nature Communications. The so-called ...

LAST 30 PRESS RELEASES:

NCSA awards 17 students Fiddler Innovation Fellowships

How prenatal alcohol exposure affects behavior into adulthood

Does the neuron know the electrode is there?

Vilcek Foundation celebrates immigrant scientists with $250,000 in prizes

Age and sex differences in efficacy of treatments for type 2 diabetes

Octopuses have some of the oldest known sex chromosomes

High-yield rice breed emits up to 70% less methane

Long COVID prevalence and associated activity limitation in US children

Intersection of race and rurality with health care–associated infections and subsequent outcomes

Risk of attempted and completed suicide in persons diagnosed with headache

Adolescent smartphone use during school hours

Alarming rise in rates of advanced prostate cancer in California

Nearly half of adults mistakenly think benefits of daily aspirin outweigh risks

Cardiovascular disease medications underused globally

Amazon Pharmacy's RxPass program improves medication adherence, helps prime members save money, study finds

Tufts University School of Medicine, ATI Physical Therapy launch first-of-its-kind collaboration to make physical therapy education and career advancement more accessible and affordable

Could lycopene—a plant extract—be an effective antidepressant?

Study shows urine test for prostate cancer could be used at home

Shaping future of displays: clay/europium-based technology offers dual-mode versatility

Optimizing ADHD treatment: revealing key components of cognitive–behavioral therapy

Breaking barriers in thioxanthone synthesis: a double aryne insertion strategy

Houston Methodist researchers identify inhibitor drugs to treat aggressive breast cancer

Skin disease patients show response to targeted treatment

Tiny copper ‘flowers’ bloom on artificial leaves for clean fuel production

Cracks in Greenland Ice Sheet grow more rapidly in response to climate change

Computer model helps identify cancer-fighting immune cells key to immunotherapy

Keeper or corner?

Printable molecule-selective nanoparticles enable mass production of wearable biosensors

Mapping the yerba mate genome reveals surprising facts about the evolution of caffeine

Electricity prices across Europe to stabilise if 2030 targets for renewable energy are met, study suggests

[Press-News.org] Expert outlines challenges of visual accessibility for people with low vision
Prentice lecture in optometry and vision science discusses new approaches to improving 'real-world' architectural and reading accessibility